AM Biotech Bio-Pulsed Exosomes entered the top 5 finalists pioneering innovation “Estée Lauder (NIV) BRKTHRU VOICES Prize” at 2024 in-Cosmetics Global

Source: https://eyeontw.com/

“Ascension Medical Biotechnology Co. Ltd.” (AM BIOTECH) is a Taiwan medical biotechnology research company, producer of patented technology Bio-Pulsed Exosomes (Extracellular Vesicles), it is a Global Cross-Generation Innovative Cosmetic Ingredient recognized and favored by the international market in Europe and America.

AM BIOTECH is the exhibitor at In-cosmetics Global (Paris, France from April 16 to April 18, 2024) for its patented Bio-pulsed Exosomes (Extracellular Vesicles) raw materials and related derivatives products. In-cosmetics Global is a leading international cosmetics tradeshow annually for worldwide network of personal care ingredients and cosmetic ingredient; the exhibition displays the best achievements in the global cosmetics industry and can be called the “Oscars Global event for the cosmetics industry”. For personal care & cosmetics ingredients exhibitors, suppliers & manufactures included outstanding top cosmetic raw material suppliers such as BASF, Croda, Ashland, Solvay, Evonik, etc., exhibiting their new generation of innovative cosmetic raw materials. Leading international cosmetics brands and manufacturers such as L’Oreal, Unilever, Procter & Gamble, Estee Lauder, Kenvue, LVMH, etc. they are looking for excellent innovative cosmetic raw materials that comply with international regulations as a new generation of cutting-edge cosmetics for development and application.

ExoGiov® is a Biochemical-pulsed exosome; developed by AM BIOTECH; specifically designed for facial beauty and hair health. It is a specific-pathogen-free (SPF) chicken embryonic mesenchymal cell-derived extracellular vesicles, which is complies with international standards and regulations acceptable worldwide (INCI: chicken embryonic mesenchymal cell-derived extracellular vesicles). The Bio-pulsed exosome with inducing activated function is a self-developed patented cosmetic ingredient in combined the key 4 pillars innovation of (Clinical breakthroughs, Product innovation, Ingredient innovation, Research and Biotechnology innovation); its excellent efficacy results surpass ordinary exosomes and common cosmetic ingredients. The results and efficacy data were also published in the international Journal of Molecular Science.

AM BIOTECH Biochemical-pulsed exosome was selected as one of the top five innovation cosmetics raw materials in the world at 2024 in-cosmetics Global by the Estée Lauder Company’s New Incubation Ventures (NIV) BRKTHRU VOICES Prize. Hence, it is not only AM BIOTECH has the honor with international affirmation in advance medical research & innovation; but also, the opportunity to expand the worldwide market internationally for ExoGiov® Biochemical Pulsed Exosomes in important professional facial beauty & haircare channels.

Dr. Richard Hsieh, Chairman and Founder of AM BIOTECH for his leading Biochemical Pulse Exosomeshe particularly emphasized that exosome manufacturers around the world are planning for globalization in the international market, and AM BIOTECH is no exception. Although South Korea, Japan and even Taiwan have opened to use human Cell-derived exosomes for cosmetic raw materials, but in order to be able to integrate with the international market, so that the products can go out of Taiwan and take a global view, they must comply with the cosmetics regulations of most mainstream international markets. It can be seen that there is no company that used human-derived exosomes has joined the 2024 In-cosmetics Global exhibition.

AM BIOTECH ExoGiov® exosome complies with international standards and regulations acceptable worldwide, which is specific-pathogen-free (SPF) chicken embryonic mesenchymal cell-derived extracellular vesicles, and the others ordinary exosomes are mostly plant-derived exosomes. Furthermore, ExoGiov® is the world’s only Bio-pulsed exosome raw material for inducing facial beauty and hair growth functions.

This innovation breakthrough is the core of ExoGiov® patented biochemical pulsed functional-inducing-exosome technology, it can precisely regulate the expression of miRNA genes to make it better than ordinary Exosomes and general cosmetic raw materials. The effectiveness of ExoGiov® are dozens of times more effective in facial beauty and hair health, such as collagen type I and type III, elastin, skin fibroblast proliferation, melanin degradation, and hair follicle cell proliferation. It has produced excellent results in all aspects.

AM BIOTECH’s latest research on promoting hair follicle cell proliferation, it was further found that Minoxidil (the active ingredient of Rogaine) has an 87% hair follicle cell proliferation rate and a 20% hair follicle cell proliferation rate with generally non-functional inducing exosomes. The hair follicle cell proliferation rate of AM BIOTECH BIO-Pulsed Exosomes is 113%, and its efficacy is very outstanding.

AM BIOTECH Bio-Pulsed Exosomes has innovation break through on this cosmetic application, the storage and the regulation limitation. ExoGiov® patented biochemical pulsed functional-inducing-exosome has the uniqueness of 99.99% high-purity exosomes and can be stored at room temperature, they comply with the international cosmetic regulations and banning exosomes derived from human cells in most countries. The exosomes are the uniqueness of 99.99% high-purity exosomes and can be stored at room temperature.Most of the exosomes currently on the market are need to be keep in frozen temperature or refrigerated in low temperature to ensure bioactivity, their application in the development and application of cosmetic products is very limited.

AM BIOTECH entered into the top five finalist’s breakthrough innovation cosmetics raw materials in the world for the Estée Lauder (NIV) BRKTHRU VOICES Prize at 2024 In-cosmetics Global. ExoGiov® BIO-Pulsed Exosomes demonstrates its development advantages in the international market, the Estée Lauder (NIV) Executive Officer Mr. Ryan J. Piela and his expert team also saw these advantages and characteristics of AM BIOTECH Biochemical-Pulsed Exosomes. This professional recognition from Estée Lauder company has also prompted many other international cosmetics brands and cosmetics ingredients distributor agents from various international countries to inquire about AM BIOTECH the exosomes business cooperation.

AM BIOTECH becomes the first Taiwan’s exosomes to enter the international market, the Glory of Taiwan.  AM BIOTECH has officially launched the ExoGiov® Bio-pulsed exosomes in use and application in the cosmetics ingredient and LA EXO® related skincare & haircare products.

Read Moreread more

【Exhibition Preview】July 25-28, AM Biotech to Showcase Innovative Technologies, Ingredients, and New Products at the Asia Healthcare & Medical Cosmetology Expo 2024

Biotechnology ✕ Beauty and Health "Asia Healthcare & Medical Cosmetology Expo 2024" showcases projects covering

Emerging Exosome Treatment Shines Hope on Chronic Kidney Disease and Renal Fibrosis

Chronic Kidney Disease (CKD) is increasingly recognized as a significant health concern worldwide. According to

AM Biotech Bio-Pulsed Exosomes entered the top 5 finalists pioneering innovation “Estée Lauder (NIV) BRKTHRU VOICES Prize” at 2024 in-Cosmetics Global

Ascension Medical Biotechnology Co. Ltd.” (AM BIOTECH) is a Taiwan medical biotechnology research company, producer

error: Content is protected !!